Zydus Lifesciences Limited — Sertraline Exporter Profile
Indian Pharmaceutical Exporter · #14 for Sertraline · $2.0M export value · DGFT Verified
Zydus Lifesciences Limited is the #14 Indian exporter of Sertraline with $2.0M in export value and 95 verified shipments. Zydus Lifesciences Limited holds a 0.8% market share in Sertraline exports across 9 countries. The company exports 81 pharmaceutical products worth $346.3M across 25 therapeutic categories.
Zydus Lifesciences Limited — Sertraline Export Profile: Buyers & Destinations
Where Does Zydus Lifesciences Limited Export Sertraline?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $573.3K | 25 | 33.3% |
| THAILAND | $449.0K | 19 | 26.1% |
| SPAIN | $275.3K | 23 | 16.0% |
| SRI LANKA | $210.0K | 6 | 12.2% |
| FRANCE | $103.3K | 15 | 6.0% |
| TAIWAN | $51.6K | 3 | 3.0% |
| UGANDA | $36.0K | 2 | 2.1% |
| LEBANON | $14.6K | 1 | 0.9% |
| KENYA | $6.9K | 1 | 0.4% |
Zydus Lifesciences Limited exports Sertraline to 9 countries. The largest destination is BRAZIL accounting for 33.3% of Zydus Lifesciences Limited's Sertraline shipments, followed by THAILAND (26.1%) and SPAIN (16.0%). These destinations reflect Zydus Lifesciences Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Sertraline from Zydus Lifesciences Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ZYDUS NIKKHO FARMACEUTICA LTDA | BRAZIL | $540.9K | 24 |
| PHARMALAND (1982) CO. LTD | THAILAND | $258.6K | 11 |
| HEMAS PHARMACEUTICALS (PVT) LTD | SRI LANKA | $210.0K | 6 |
| LABORATORIOS COMBIX SLU | SPAIN | $113.8K | 9 |
| CENTRE SPECIALITES PHARMACEUTIQUES | FRANCE | $100.1K | 12 |
| PHARMALAND (1982) CO.LTD | THAILAND | $65.2K | 4 |
| PHARMALAND (1982) CO., LTD. | THAILAND | $63.3K | 2 |
| DHL GLOBAL FORWARDING (SPAIN) | SPAIN | $42.1K | 4 |
| DHL GLOBAL FORWARDING (SPAIN). | SPAIN | $37.2K | 4 |
| CHI FU TRADING CO. LTD | TAIWAN | $36.4K | 2 |
Zydus Lifesciences Limited supplies Sertraline to 22 buyers globally. The largest buyer is ZYDUS NIKKHO FARMACEUTICA LTDA (BRAZIL), followed by PHARMALAND (1982) CO. LTD (THAILAND) and HEMAS PHARMACEUTICALS (PVT) LTD (SRI LANKA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Sertraline Export Value and How Much Does Zydus Lifesciences Limited Contribute?
India exported $150.8M worth of Sertraline through 5,183 shipments from 218 suppliers to 88 countries, serving 553 buyers globally. Zydus Lifesciences Limited contributes $2.0M to this total, accounting for 0.8% of India's Sertraline exports. Zydus Lifesciences Limited ships Sertraline to 9 countries through 22 buyers.
What Is the Average Shipment Value for Zydus Lifesciences Limited's Sertraline Exports?
Zydus Lifesciences Limited's average Sertraline shipment value is $20.9K per consignment, based on 95 shipments totaling $2.0M. The largest destination is BRAZIL (33.3% of Zydus Lifesciences Limited's Sertraline exports).
How Does Zydus Lifesciences Limited Compare to Other Indian Sertraline Exporters?
Zydus Lifesciences Limited ranks #14 among 218 Indian Sertraline exporters with a 0.8% market share. The top 3 exporters are AUROBINDO PHARMA LTD ($34.1M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($32.1M), CIPLA LIMITED ($27.5M). Zydus Lifesciences Limited processed 95 shipments to 9 destination countries.
What Sertraline Formulations Does Zydus Lifesciences Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| PHARMA DRUGS & MEDICINE-SERTRALINE TABS | $124.1K | 3 |
| SERLIN 50 (SERTRALINE 50MG TAB 3X10T) | $97.6K | 4 |
| SERLIN 50MG TABS (SERTRALINE HYDROCHLORIDE TABLETS USP 50MG) 10X10 UNDER LUT NO.AD300323000664T DT.16.03.2023 VALID UPNOS | $96.7K | 2 |
| PHARMACEUTICALS MEDICINE FOR HUMAN USE-SERTRALINE HYDR TAB USP100MG 30S SALE BR(SERTRALINE) 3X10S-QTY-54,472.000 PAC AS | $67.8K | 3 |
| SERLIN 50MG TABS (SERTRALINE) 10 X 10 UNDER LUT NO.AD300323000664T DT.16.03.2023VALID UP TO DT.31.03.2024NOS | $58.1K | 2 |
| SERLIN 50 TABLETS (SERTRALINE TABS BP 50MG) 3X10T | $57.3K | 2 |
| SERLIN 50MG TABS (SERTRALINEN 50MG) 10X10 SHIPMENT UNDER LUT No.AD300324000860VDated 21.03.2024 valid up to 31.03.2025 | $55.2K | 2 |
| SERTRALINE TABS 50MG (SERTRALINE HYDROCHLORIDE) 3X10 QTY-252,331.000 PAC-AS PERINV | $50.0K | 1 |
| PHARMACEUTICALS MEDICINE FOR HUMAN USE-SERTRALINE TABS 50MG (SERTRALINE HYDROCHLORIDE) 3X10 QTY-126,126.000 PAC | $50.0K | 1 |
| Sertraline Hydrochloride T USP 50mg30S B(SERTRALINE) (BATCH NO.G400971;G400972;G401276 MFG.DT. 04/2024 EXP.DT. 03/2027) | $50.0K | 1 |
Zydus Lifesciences Limited exports 61 distinct Sertraline formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARMA DRUGS & MEDICINE-SERTRALINE TABS with 3 shipments worth $124.1K.
Regulatory Requirements: Exporting Sertraline to Key Markets
What Zydus Lifesciences Limited must comply with to export Sertraline to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Zydus Lifesciences Limited Compare to Nearest Sertraline Exporters?
Exporters ranked immediately above and below #14 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | TORRENT PHARMACEUTICALS LIMITED | $2.4M | 47 | 5 | $50.0K |
| 13 | INTAS PHARMACEUTICALS LIMITED | $2.3M | 414 | 12 | $5.6K |
| 14 | ZYDUS LIFESCIENCES LIMITED ★ | $2.0M | 95 | 9 | $20.9K |
| 15 | EMIL PHARMACEUTICAL INDUSTRIES PVT LTD | $1.8M | 53 | 3 | $34.6K |
Zydus Lifesciences Limited ranks #14 among 218 Indian Sertraline exporters. Average shipment value of $20.9K compared to the market average of $691.9K. The closest competitors by value are TORRENT PHARMACEUTICALS LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Sertraline Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 592 | 11.4% |
| SAHAR AIR | 498 | 9.6% |
| NHAVA SHEVA SEA (INNSA1) | 382 | 7.4% |
| DHANNAD ICD | 268 | 5.2% |
| HYDERABAD ICD | 184 | 3.6% |
| DHANNAD ICD (INDHA6) | 177 | 3.4% |
| DELHI AIR | 173 | 3.3% |
| VIZAG SEA (INVTZ1) | 172 | 3.3% |
Geopolitical & Trade Policy Impact on Zydus Lifesciences Limited's Sertraline Exports
Zydus Lifesciences's export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic logistics planning to mitigate potential delays and cost escalations.
Conversely, U.S.-China trade tensions have opened opportunities for Indian pharmaceutical companies like Zydus to capture a larger share of the U.S. market, as American importers seek alternative suppliers. Zydus's recent FDA approvals, including Niacin ER Tablets and Leuprolide Acetate injection, position the company to capitalize on this shift. (ainvest.com)
In the European Union, compliance with the Falsified Medicines Directive (FMD) is crucial for market access. Zydus's proactive measures to align with these regulations enhance its credibility and competitiveness in the EU market. However, the ongoing Israel-Iran conflict poses risks to Middle East trade routes, potentially affecting Zydus's operations in that region.
Zydus Lifesciences Limited — Regulatory Compliance & Quality Standards
Maintaining stringent quality standards is paramount for Zydus Lifesciences. In October 2025, the company received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from the U.S. FDA for its Baddi manufacturing facility, indicating compliance with regulatory standards. (bajajbroking.in) Similarly, the Ahmedabad SEZ-II facility received a clean USFDA report in November 2025, further affirming the company's commitment to quality. (bajajbroking.in)
These regulatory approvals are critical, as non-compliance can lead to import bans and reputational damage. Zydus's adherence to Good Manufacturing Practices (GMP) and proactive engagement with regulatory bodies underscore its dedication to maintaining high-quality standards across its operations.
About Zydus Lifesciences Limited
Zydus Lifesciences Limited exports 81 products worth $346.3M. Beyond Sertraline, top products include Losartan, Carvedilol, Iron, Mesalamine, Omeprazole. View the complete Zydus Lifesciences Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sertraline — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sertraline shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Zydus Lifesciences Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 95 individual customs records matching Zydus Lifesciences Limited exporting Sertraline, covering 61 formulations to 9 countries via 22 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 88+ countries, 553+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sertraline Export Data from Zydus Lifesciences Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Zydus Lifesciences Limited's Sertraline exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Zydus Lifesciences Limited
Full Company Profile →
81 products · $346.3M total trade · 25 categories
Sertraline Stats
Company Overview
Top Products by Zydus Lifesciences Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Zydus Lifesciences Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sertraline. For current shipment-level data, contact TransData Nexus.